Please login to the form below
Nestle
This page shows the latest Nestle news and features for those working in and with pharma, biotech and healthcare.
P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit
P&G has won the unit despite interest from other partners, including Nestle, Novartis and reportedly Mylan, which as recently as last week was said to be in advanced negotiations.
Latest news
-
GSK joins Reckitt in passing on Pfizer’s consumer health unit
Other companies linked to a possible purchase in the past include Procter &Gamble, Johnson &Johnson and Abbott, as well as food group Nestle, but Pfizer’s deadline for bids came to ... speculation at the time that it might be because of a disagreement
-
Pfizer could raise ‘up to $15bn’ from consumer unit sale
There is speculation that companies potentially interested in a deal could include GlaxoSmithKline (GSK), Reckitt Benckiser, Procter &Gamble, Johnson &Johnson and Abbott, while Reuters has suggested food giant Nestlé may also
-
Sanofi and Ablynx sign €2.4bn nanobody deal
We are particularly excited by the Ablynx technology as a leading biologics platform, enabling the development of transformative multi-targeting treatment approaches, ”said Franke Nestle, managing director of Sanofi’s global
-
Microbiome specialist Rebiotix chalks up C. diff trial success
Johnson &Johnson's Janssen unit has set up a research institute dedicated to microbiome studies, and food giant Nestle is also getting involved with a $1.9bn partnership with microbiome specialist
-
Nestlé Health Science invests $145m in food allergy biotech
Nestlé Health Science invests $145m in food allergy biotech. Aimmune Therapeutics' lead product is a phase III peanut allergy treatment. ... The deal will also see Nestlé Health Science's CEO Greg Behar take a seat on the Aimmune Board.
More from news
Approximately 5 fully matching, plus 49 partially matching documents found.
Latest Intelligence
-
Change in the pharma industry is inevitable
The likes of Coca Cola, Pepsi, Nestle and Kelloggs look destined to join tobacco companies as society’s pariahs - for pushing harmful sugar-laden drinks and foods on to children and
-
Deal Watch November 2016
licence, collaboration. 167. Aimmune Therapeutics/ Nestlé Health Science. CODIT (Characterised Oral Desensitisation ImmunoTherapy), for treating life-threatening food.
-
Charting a course for expansion
Dysport is part of Ipsen's partnership with Galderma that sees Nestlé's skin care business manage its aesthetics business while Ipsen has the therapeutics side.
-
Healthcare business and operating models redefined
How critical healthcare needs can be met more efficiently and effectively
-
SEO for the healthcare industry
is head of digital marketing for Vitaflo - a Nestlé health science company. .
More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.
Latest appointments
-
Belgium's TiGenix appoints Dr Gregory Gordon
Dr Gordon joins TiGenix from Nestlé Health Science, where he was global clinical affairs lead, gastrointestinal health and prior to that he has worked at Stealth BioTherapeutics, Ironwood Pharmaceuticals and Parexel.
-
Celgene’s president and COO to retire
Previously, Dr Fouse was chief financial officer of agribusiness and food company Bunge, and also brought executive leadership expertise from Alcon Laboratories and Nestlé.
-
Sanofi appoints immunology and inflammation research global head
Sanofi appoints immunology and inflammation research global head. Dr Frank Nestle also becomes North America chief scientific officer. ... Sanofi has appointed Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic
-
New head of strategy for Saatchi & Saatchi Health
Critchley's previous experience includes roles at advertising firms Bates UK and JWT, which she worked on major brands, including Smirnoff vodka and several Nestlé products, including Rolos and Smarties.
-
Havas Life hires Carola Salvato as general manager, Italy
With experience that spans medical communications, market strategies, branding, CRM and PR; Salvato has worked with clients such as Abbott, Abbvie, Bracco, Danone, Dompé, Lilly, Nestlé, MSD Animal Health, Novartis, Pfizer
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Market Access Transformation
Pfizer. Janssen. Novartis. Roche. Jazz Pharmaceuticals. Amgen. GSK. Nestle. Gilead. BMS.
-
How the focus on patient outcomes has allowed FMCG to enter into healthcare market
Of FMCG companies, Procter &Gamble, Walmart and Nestle have entered the pharmaceutical industry providing healthcare services.
-
Random42 Scientific Communication
Mesoblast. Mundipharma. NAPP. National Geographic. NHS. Nestle Health Science. Novartis. Novartis Vaccines and Diagnostics.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
-
Scientific Director
-
Great salary and bebefits
-
Senior Medical Writer
-
Great salary and bebefits
-
Senior Programme Executive
-
Salary TBC
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Account Manager – Med Comms – London
-
Salary TBC
- Senior Account Manager / Account Director
-
Great salary and bebefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
Subscribe to our email news alerts
- Shire warms to Takeda’s latest offer, extending deadline
- Otsuka finally gets FDA OK for kidney disease drug
- Pfizer takes aim at UK’s health tech industry
- Morning brief: Takeda closes in on $64bn merger, GSK unveils team, and more
- It’s nice, but it’s not an infographic
- PureTech Health appoints new chief financial officer
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
- The Holy Grail of HCP Access
- This is the data you need to gain access....
Quick links
Infographics
